PetVivo Holdings, Inc.

PetVivo Holdings, Inc., a veterinary biotech and biomedical device company, engages in the licensing and commercializing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Kush, a veterinarian-administered joint injection for the treatment of osteoarthritis and lameness in dogs and horses. The company's pipeline products include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Minneapolis, Minnesota.

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

Spryng™ with OsteoCushion™ Technology

PetVivo, Inc is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics. PetVivo believes that it can leverage the investments in the human biomaterials and medical device industries to commercialize therapeutics to pets in a capital and time efficient way. PetVivo's strategy is to in-license proprietary products from human medical device companies specifically for use in pets.  PetVivo, Inc, Gel-Del Technologies, Inc. and CosmetaLife a Corporation are all wholly-owned subsidiaries of PetVivo Holdings, Inc.

PetVivo Holdings Inc

Dr. Jeremy Caplin Joins PetVivo Holdings, Inc. as the Director of Research, read more here: https://lnkd.in/eYevYm6p

PetVivo Holdings, Inc. Begins Process to Pursue Approval of Biomatrix Particulate Technology for Initial Human Indication. Read more here: https://lnkd.in/g8ebpNHP

Markets Hunter Live with Dr. Michael Sterns: https://lnkd.in/gDnpaQiC

Dr. Thomas Yarbrough Joins PetVivo Holdings, Inc. as the Senior Research Director. Read more here: https://lnkd.in/gMmSJ6XE

Dr. Maureen Dower Joins PetVivo Holdings, Inc. as a Senior Technical Services Veterinarian. Read more here: https://lnkd.in/gciC5QQ4

Trina Lally Joins PetVivo Holdings, Inc. as the Northeast Business Development Manager! Read more here: https://lnkd.in/gdJqEiqH

Interview with Spencer Breithaupt the latest board member to PetVivo. His knowledge and experience in helping spread the word on Spryng with Osteocushion technology. A very effective and innovative tool in the management of osteoarthritis, lameness, and other joint afflictions. Check out the interview here: https://lnkd.in/gc-vrqkp

We are #hiring a Marketing Specialist with Animal Health Experience! Know anyone who might be interested?https://lnkd.in/g7S9HXAJ

PETVIVO HOLDINGS, INC. TO PRESENT AT AEGIS CAPITAL VIRTUAL CONFERENCE ON MAY 2-4, 2023. Read more here: https://lnkd.in/g-ghi3DB

NASDAQ:PETVW

PetVivo Holdings, Inc.

Last Close

0.56

08/11 20:00

Market Cap

9.12M

Beta: -

Volume Today

17.73K

Avg: -

PE Ratio

−1.45

PFCF: −2.24

Analysis Not Available